Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial
Journal of Clinical Oncology · 2026
DOI: 10.1200/jco-25-02234 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, 2026. Verfasst von Youngju Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy, Salvage Therapy, Neoplasm Recurrence, Local. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
PURPOSE To compare hypofractionated radiotherapy (RT) with conventional RT for treating biochemical recurrence following radical prostatectomy. METHODS Between 2019 and 2021, 316 patients with intermediate- to high-risk prostate cancer were randomly assigned to receive salvage RT with either 65 Gy in 26 fractions (hypofractionated RT, HYPO) or 66 Gy in 33 fractions (conventional RT, CONV). RT was delivered to the prostate bed, with elective pelvic nodal irradiation performed at the discretion of radiation oncologists. Intensity-modulated RT with daily image guidance was used. The primary end point was biochemical progression-free survival (bPFS). Secondary end points included distant metastasis-free survival (DMFS), prostate cancer–specific survival (CSS), toxicity profiles, and patient-reported quality-of-life. RESULTS One hundred fifty-one patients (51.2%) received androgen deprivation therapy, and 202 (68.5%) underwent elective nodal irradiation. Endorectal balloons were used in 186 men (63.1%). The median pre-RT prostate-specific antigen level was 0.36 ng/mL (IQR, 0.24-0.49 ng/mL). After a median follow-up of 52.6 months, the 4-year bPFS rates were 80.1% and 78.1% in the HYPO and CONV arms, respectively. There were no significant differences in DMFS (91.7% v 91.0%) and CSS (100% v 100%). The 4-year cumulative incidence of grade ≥2 GI toxicity was higher in the HYPO arm (7.9% v 0.7%), predominantly among patients without an endorectal balloon; all cases were resolved by the last follow-up. Patient-reported quality-of-life outcomes were comparable. CONCLUSION bPFS was not superior in the HYPO arm at 4 years. However, given the comparable oncologic outcomes, toxicity profiles, and quality-of-life measures, hypofractionated RT may be considered a viable alternative in the salvage setting. Further research is needed to determine whether the use of an endorectal balloon reduces GI toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Urology, Kangwon National University Hospital, Chuncheon-si, Republic of Korea.
- Department of Medical Informatics & Statistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Youngju Song, Hongryull Pyo, Yeon Joo Kim, Hanjong Ahn, Hwa Jung Kim, Young Seok Kim
Zitieren
APA
Song, Y., Park, W., Pyo, H., Kim, Y. J., Ahn, H., Kim, H. J., & Kim, Y. S. (2026). Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02234
Vancouver
Song Y, Park W, Pyo H, Kim YJ, Ahn H, Kim HJ, et al. Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial. Journal of Clinical Oncology. 2026. doi:10.1200/jco-25-02234
BibTeX
@article{Song2026,
author = {Song, Youngju and Park, Won and Pyo, Hongryull and Kim, Yeon Joo and Ahn, Hanjong and Kim, Hwa Jung and Kim, Young Seok},
title = {Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial},
journal = {Journal of Clinical Oncology},
year = {2026},
doi = {10.1200/jco-25-02234}
}
EUVIMED